• LAST PRICE
    2.9200
  • TODAY'S CHANGE (%)
    Trending Up0.1000 (3.5461%)
  • Bid / Lots
    2.9200/ 3
  • Ask / Lots
    3.0100/ 178
  • Open / Previous Close
    2.8300 / 2.8200
  • Day Range
    Low 2.7800
    High 3.1400
  • 52 Week Range
    Low 1.6700
    High 5.2500
  • Volume
    211,195
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 2.82
TimeVolumeORMP
09:32 ET68742.8
09:36 ET5002.825
09:38 ET31852.84
09:39 ET34742.89
09:41 ET32382.885
09:43 ET1002.9
09:45 ET5402.91
09:48 ET4002.91
09:50 ET4002.91
09:52 ET6002.93
09:54 ET19302.93
09:56 ET22982.9301
09:57 ET2002.935
09:59 ET1002.93
10:01 ET2002.935
10:03 ET2002.945
10:06 ET4002.93
10:08 ET9342.94
10:10 ET1002.94
10:12 ET6602.955
10:14 ET1002.955
10:15 ET3002.945
10:19 ET7202.95
10:21 ET1002.955
10:24 ET11002.955
10:26 ET6002.945
10:30 ET2002.945
10:32 ET2002.945
10:33 ET2002.945
10:37 ET4002.94
10:39 ET34602.96
10:42 ET1002.97
10:44 ET4002.97
10:46 ET4002.99
10:48 ET244843.01
10:50 ET17303.01
10:51 ET32873.05
10:53 ET2003.055
10:55 ET39903.02
10:57 ET34003.04
11:00 ET11003.0501
11:02 ET2003.07
11:04 ET46223.06
11:06 ET4403.09
11:08 ET26853.1113
11:09 ET62913.08
11:13 ET2403.09
11:15 ET2003.0811
11:20 ET4003.1
11:22 ET6003.1
11:24 ET2893.1017
11:26 ET14003.12
11:27 ET11703.1001
11:29 ET4003.115
11:31 ET12673.08
11:33 ET13003.055
11:36 ET77902.99
11:38 ET36553.01
11:40 ET23002.9901
11:42 ET7202.98
11:44 ET7002.97
11:45 ET10702.96
11:54 ET2002.965
11:56 ET16003.01
12:00 ET21842.97
12:03 ET12002.97
12:07 ET10002.97
12:09 ET3002.97
12:12 ET1002.97
12:14 ET31302.94
12:16 ET5002.93
12:18 ET8002.95
12:20 ET2002.945
12:25 ET14002.92
12:30 ET40822.91
12:32 ET3002.905
12:36 ET18402.9
12:38 ET54102.9
12:39 ET2002.89
12:41 ET28402.895
12:43 ET2002.9
12:45 ET14002.8922
12:52 ET12502.915
12:54 ET9862.9189
12:56 ET37782.94
12:57 ET12802.94
12:59 ET10002.93
01:01 ET13002.93
01:03 ET1002.935
01:10 ET4402.9399
01:12 ET3002.935
01:17 ET8002.925
01:26 ET3002.93
01:28 ET4002.95
01:33 ET1002.945
01:35 ET5002.94
01:39 ET1002.93
01:44 ET4002.915
01:46 ET1002.915
01:48 ET1002.9189
01:51 ET2002.92
01:55 ET13002.925
02:02 ET1002.92
02:08 ET1002.925
02:09 ET1902.925
02:13 ET2002.925
02:20 ET3002.925
02:22 ET1002.925
02:26 ET6002.9215
02:27 ET1002.925
02:29 ET47482.91
02:31 ET5002.9015
02:33 ET1002.905
02:36 ET7002.905
02:40 ET3002.91
02:42 ET7282.915
02:47 ET3002.91
02:56 ET4002.91
02:58 ET16732.93
03:02 ET1002.945
03:05 ET3002.945
03:09 ET1002.945
03:12 ET1002.945
03:16 ET1002.945
03:18 ET1002.945
03:20 ET2002.945
03:23 ET3002.945
03:25 ET1002.945
03:27 ET59502.935
03:30 ET2002.94
03:32 ET2002.94
03:34 ET2002.945
03:36 ET42922.93
03:41 ET3002.93
03:43 ET6972.93
03:48 ET9902.92
03:50 ET11002.9263
03:52 ET13672.92
03:54 ET19202.93
03:56 ET3002.92
03:57 ET16002.92
03:59 ET19782.92
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesORMP
Oramed Pharmaceuticals Inc
114.3M
23.0x
---
United StatesIOBT
IO Biotech Inc
114.0M
-0.8x
---
United StatesVIGL
Vigil Neuroscience Inc
114.8M
-1.6x
---
United StatesALLK
Allakos Inc
112.5M
-0.6x
---
United StatesTGRP
Nanopharmaceutics Inc
104.4M
-178.6x
---
United StatesIMUX
Immunic Inc
116.9M
-0.6x
---
As of 2024-03-28

Company Information

Oramed Pharmaceuticals Inc. is a pharmaceutical company, which is engaged in the research and development of pharmaceutical solutions with its technology platform. Its POD (Protein Oral Delivery) technology has been designed to protect orally delivered proteins from detrimental enzymatic activity within the gastrointestinal tract and to enhance their absorption across the intestinal wall. Its pipeline includes ORMD-0801 diabetes, ORMD-0901, and ORMD-0801 non-alcoholic steatohepatitis (NASH). Its flagship product, ORMD-0801, allows insulin to travel from the gastrointestinal tract via the portal vein to the liver. It is conducting Phase III trials in patients with type 2 diabetes. It is also developing an oral Glucagon-like peptide-1 (GLP-1) analog capsule (ORMD-0901), which is an incretin hormone, that stimulates the secretion of insulin from the pancreas. It is also engaged in the research and development of an oral vaccine for COVID-19 through its subsidiary, Oravax Medical Inc.

Contact Information

Headquarters
1185 AVENUE OF THE AMERICAS, 3RD FLOORNEW YORK, NY, United States 10036
Phone
646-844-1164
Fax
845-818-3588

Executives

Chairman of the Board, President, Chief Executive Officer
Nadav Kidron
Chief Financial Officer, Treasurer
David Silberman
Chief Operating and Business Officer
Joshua Hexter
Chief Scientific Officer, Director
Miriam Kidron
General Counsel, Company Secretary, Chief Legal Officer
Netanel Derovan

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$114.3M
Revenue (TTM)
$1.3M
Shares Outstanding
40.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.80
EPS
$0.13
Book Value
$4.06
P/E Ratio
23.0x
Price/Sales (TTM)
85.3
Price/Cash Flow (TTM)
21.6x
Operating Margin
-1,176.79%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.